DNA methylation is one of the main epigenetic modifications in the eukaryotic genome and has been shown to play a role in cell-type specific regulation of gene expression, and therefore cell-type identity. Bisulfite sequencing is the gold-standard for measuring methylation over the genomes of interest. Here, we review several techniques used for the analysis of high-throughput bisulfite sequencing. We introduce specialized short-read alignment techniques as well as pre/post-alignment quality check methods to ensure data quality. Furthermore, we discuss subsequent analysis steps after alignment. We introduce various differential methylation methods and compare their performance using simulated and real bisulfite-sequencing datasets. We also discuss the methods used to segment methylomes in order to pinpoint regulatory regions. We introduce annotation methods that can be used further classification of regions returned by segmentation or differential methylation methods. Lastly, we review software packages that implement strategies to efficiently deal with large bisulfite sequencing datasets locally and also discuss online analysis workflows that do not require any prior programming skills. The analysis strategies described in this review will guide researchers at any level to the best practices of bisulfite-sequencing analysis.
Introduction
Cytosine methylation (5-methylcytosine, 5mC ) is one of the main covalent base modifications in eukaryotic genomes. It is involved in epigenetic regulation of gene expression in a cell type specific manner. It can be added or removed and can remain stable throughout cell division. Classical understanding of DNA methylation is that it silences gene expression when occurs at a CpG rich promoter region [1] . It occurs predominantly on CpG dinucleotides and seldom on non-CpG bases in metazoan genomes. The non-CpG methylation has been mainly observed in human embryonic stem and neuronal cells [2] , [3] . There are roughly 28 million CpGs in the human genome, 60-80% are generally methylated. Less than 10% of CpGs occur in CG-dense regions that are termed CpG islands in the human genome [4] . It has been demonstrated that DNA methylation is also not uniformly distributed over the genome and associated with CpG density. In vertebrate genomes, the cytosines are usually unmethylated in CpG-rich regions such as CpG islands and methylated in CpG-deficient regions. The vertebrate genomes are largely CpG deficient except at CpG islands. On the contrary, invertebrates such as Drosophila melanogaster and Caenorhabditis elegans do not have cytosine methylation and associated with this feature, they do not have CpG rich and poor regions but rather a steady CpG frequency over the genome [5] . DNA methylation is established by DNA methyltransferases DNMT3A and DNMT3B in combination with DNMT3L and maintained through/after cell division by the methyltransferase DNMT1 and associated proteins. DNMT3a and DNMT3b are in charge of the de novo methylation during early development. Loss of 5mC can be achieved passively by dilution during replication or exclusion of DNMT1 from the nucleus. Recent discoveries of ten-eleven translocation (TET) family of proteins and their ability to convert 5-methylcytosine (5mC) into 5-hydroxymethylcytosine (5-hmC) in vertebrates provide a path for catalysed active DNA demethylation [6] . Iterative oxidations of 5-hmC catalysed by TET result in 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC). 5caC mark is excised from DNA by G/T mismatch-specific thymine-DNA glycosylase (TDG), which as a result returns cytosine residue back to its unmodified state [7] . Apart from these, mainly bacteria but possibly higher eukaryotes contain base modifications on other bases than cytosine, such as methylated adenine or guanine [8] .
One of the most reliable and popular ways to measure DNA methylation is bisulfite sequencing. These and related methods allow measuring DNA methylation at the single nucleotide resolution. In this review, we will describe strategies for analyzing data from bisulfite sequencing experiments. First, we will introduce high-throughput sequencing techniques based on bisulfite treatment. Next, we summarize algorithms and tools for detecting differential methylation and methylation profile segmentation. Lastly, we will discuss how to deal with large datasets and data analysis workflows with guided user interface. The computational workflow summarizing all the necessary steps is shown in Figure 1 .
Bisulfite sequencing for detection of methylation and other base modifications
Approaches that enable profiling genome-wide DNA methylation fall into four categories: methods based on restriction enzymes sensitive to DNA methylation (such as MRE-seq), methylcytosine-specific antibodies (such as methylated DNA immunoprecipitation (MeDIP [9] ), methyl-CpG-binding domains to enrich for methylated DNA at sites of interest [10] and those based on sodium bisulfite treatment. However, the first three methods allow to detect methylation over measured regions ranging in size from 100 to 1000 bp. Methods that use sodium bisulfite treatment, which converts unmethylated cytosines to thymine (via uracil) while methylated cytosines remain protected, measure DNA methylation at single nucleotide resolution [11] . For the remainder of this section, we will focus on bisulfite-conversion based sequencing techniques.
The whole genome bisulfite sequencing (WGBS) is considered as the 'gold standard' for DNA methylation measurement due to whole-genome coverage and the single-base resolution. Briefly, it combines bisulfite conversion of DNA molecules with high-throughput sequencing. To perform WGBS, the genomic DNA is first randomly fragmented to desired size (200 bp). The fragmented DNA is converted into a sequencing library by ligation to adaptors that contain 5-mCs. The sequence library is then treated with bisulfite. This treatment effectively converts unmethylated cytosines to uracil. After amplifying the library treated with bisulfite by PCR, it is sequenced using high-throughput sequencing. After the PCR, uracils will be represented as thymines. A precise recall of cytosine methylation does not only require sufficient sequencing depth but also strongly depends on the quality of bisulfite conversion and library amplification. The benefits of this shotgun approach is that it typically reaches a coverage >90% of the CpGs in the human genome in unbiased representation. It allows identification of non-CG methylation as well as identification of partially methylated domains (PMDs, [2] ), low methylated regions at distal regulatory elements (LMRs, [12] ) and DNA methylation valleys (DMVs) in embryonic stem cells [13] . Despite its advantages, WGBS remains the most expensive technique and usually is not applied to large number of samples and requires relatively large quantities of DNA (100ng-5 ug) [14] . To achieve high sensitivity of detecting methylation differences between samples, high sequencing depth is required which leads to significant increase in sequencing cost.
The reduced representation bisulfite sequencing (RRBS) is another technique, which can also profile DNA methylation at single-base resolution. It combines digestion of genomic DNA with restriction enzymes and sequencing with bisulfite treatment in order to enrich for areas with a high CpG content. Therefore it relies first on digestion of genomic DNA with restriction enzymes, such as MspI which recognises 5'-CCGG-3' sequences and cleaves the phosphodiester bonds upstream of CpG dinucleotide. It can sequence only CpG dense regions and doesn't interrogate CpG-deficient regions such as functional enhancers, intronic regions, intergenic regions or in general lowly methylated regions of the genome. It has limited coverage of the genome in CpG poor regions and examines about 4% to 17% of the approximately 28 million CpG dinucleotides distributed throughout the human genome depending on the sequencing depth and which variant of RRBS is used [15, 16] .
Targeted Bisulfite sequencing also uses a combination of bisulfite sequencing with high-throughput sequencing, but it needs a prior selection of predefined genomic regions of interest. Frequently used protocols employ either PCR amplification of regions of interest [17, 18] , padlock probes [19] , or hybridization-based target enrichment [20] .
One of the major assay specific issues is the fact that bisulfite sequencing can not discriminate between hydroxymethylation (5-hmC) and methylation (5-mC) [21] . Hydroxymethylation converts to cyto-5-methanesulfonate upon bisulfite treatment, which then reads as a C when sequenced [21] . Furthermore, 5-hmC mediated by TET proteins is a mechanism of non-passive DNA demethylation. Therefore, methylation measurements for tissues having high 5-hydroxymethylation will not be reliable at least in certain genomic regions. The development of Tet-assisted bisulfite sequencing (TAB-seq) [22] and oxBS-Seq [23] enabled to distinguish between the two modifications at single base resolution. In addition to 5-hmC, single-base resolution mapping of 5caC using CAB-seq [24] and detection of 5fc (fCAB-seq [25, 26] and redBS-Seq [25, 26] ) in mammalian genomes has recently been achieved.
Alignment and data processing for bisulfite sequencing
Since BS-seq changes unmethylated cytosines (C) to thymines (T), subsequent steps for analysis aim for counting the number of C to T conversions and quantifying the methylation proportion per base. This is simply done by identifying C-to-T conversions in the aligned reads and dividing number of Cs by the sum of Ts and Cs for each cytosine in the genome. Being able to do the quantification reliably depends on quality control before alignment, the alignment methods and post-alignment quality control.
Since base-calling quality is not constant and could change between sequencing runs and within the same read, it is important to check the base quality, which represents the level of confidence in the base calls. Miscalled bases can be counted as C-T conversions erroneously. If possible such errors should be avoided. This basic quality check can be done via fastQC software (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/). In addition, sometimes adapters can be sequenced and if not properly removed they will either lower the alignment rates or can cause false C-T conversions. We recommend trimming low quality bases on sequence ends and removing adapters to minimize issues with false C-T conversions and increasing the alignment rates. This can be achieved using trimming programs such as Trim Galore (http://www.bioinformatics.babraham.ac.uk/projects/trim_galore/).
Once pre-alignment quality control and processing is done, the next step is the alignment where the algorithms should be able to deal with potential C-T conversions. The BS-seq alignment methods mostly rely on modifications of known short-read alignment methods. For example, Bismark relies on Bowtie and in silico C-T conversion of reads and genomes [27] . Many other aligners use this in silico conversion strategy, such as: MethylCoder [28] , BS-seeker2 [29] , BRAT-BW [30] and Bison [31] . Other methods, such as Last [32] , uses a specific score matrix that can tolerate C-T mismatches or ,such as BSMAP [33] , masks Ts in the reads and matches them to genomic Cs. There are not many comprehensive benchmarks of the aligners since there is a new one coming frequently, but earlier attempts to compare the performance of the aligners did not find intolerable differences between aligners [34, 35] . In addition, tool developers usually spend more time optimizing their tool for the benchmark than optimizing the competing tools when preparing publications. For us, there is no compelling evidence that an established tool such as Bismark is significantly worse or better in accuracy than the competing tools. For our own work, we frequently use Bismark since it provides BAM files, as well as additional methylation call related metrics and files.
After the alignment and methylation calling, there is still a need for further quality control. One of the potential problems with bisulfite sequencing is incomplete conversion, where not all unmethylated Cs are converted to Ts. Incomplete conversion causes false positives results due to interpretation of the unconverted unmethylated cytosines as methylated. For species without major non-CpG methylation, such as human, we can calculate the conversion rate by using the percentage of non-CpG methylation. For a high quality experiment, we expect the conversion rate to be as close to 100% as possible, typical values for a good experiment will be higher than 99.5%. Another way to measure conversion rate is to add spike-in sequences with unmethylated Cs and counting the number of Ts for unmethylated Cs. Degradation of DNA during bisulfite treatment is another potential problem. Long incubation time and high bisulfite concentration, can lead to the degradation of about 90% of the incubated DNA [36] . Therefore, it is crucial to check unique alignment rates and read lengths after trimming. Other post-alignment quality metrics include removing known C/T SNPs which can interfere with methylation calls. The last post-alignment quality procedure is to deal with PCR bias. A simple way could be to remove reads that align to the exact same genomic position on the same strand. This de-duplication can be performed using the "samtools rmdup" command or Bismark tools. For RRBS, due to experimental procedures removing PCR duplicates by looking at overlapping coordinates of reads is not advised. Instead, one can try to remove PCR bias by removing regions with unusually high coverage, this method produces concurrent methylation measurements with orthogonal methods such as pyrosequecing [37] .
Differential methylation methods
Once we have methylation proportions per base, we would generally proceed to discover the dynamics of methylation profiles. When there are multiple sample groups, it is usually of interest to locate bases or regions with different methylation proportions across samples. These bases or regions with different methylation proportions across samples are called differentially methylated CpG sites (DMCs) and differentially methylated regions (DMRs). They have been shown to play a role in many different diseases due to their association to epigenetic control of gene regulation. In addition, DNA methylation profiles can be highly tissue-specific due to their involvement in gene regulation [38] . DNA methylation is highly informative when studying normal and diseased cells, because it can also act as a biomarker [39] . For example, the presence of large-scale abnormally methylated genomic regions is a hallmark feature of many types of cancers [40] . Because of aforementioned reasons, investigating differential methylation is usually one of the primary goals of doing bisulfite sequencing.
We will first discuss the methods for identifying DMCs. Differential DNA methylation is usually calculated by comparing the proportion of methylated Cs in a test sample relative to a control. In simple comparisons between such pairs of samples (i.e. test and control), methods such as Fisher's Exact Test (implemented in methylkit [41] , RnBeads [42] along with many other tools) can be applied when there are no replicates for test and control cases. There are also methods based on hidden Markov models (HMMs) such as ComMet, included in the Bisulfighter methylation analysis suite [43, 44] . These tools are sufficient to compare one test and one control sample at a time and if there are replicates; replicates can be pooled within groups to a single sample per group [41] . This strategy, however, does not take into account biological variability between replicates.
Regression based methods are generally used to model methylation levels in relation to the sample groups and variation between replicates. Differences between currently available regression methods stem from the choice of distribution to model the data and the variation associated with it. In the simplest case linear regression can be used to model methylation per given CpG or loci across sample groups. The model fits regression coefficients to model the expected methylation proportion values for each CpG site across sample groups. Following that, the null hypothesis of the model coefficients being zero could be tested using t-statistics. Such models are available in the limma package [45] . Limma was initially developed for the detection of differential gene expression in microarray data, but it is also used for methylation data. It is the default method applied in RnBeads [46] . It uses moderated t-statistics in which standard errors have been moderated across loci, i.e. shrunk towards a common value using Empirical Bayes method. Another method that relies on linear regression and t-test is BSmooth [47] method. The main difference is that BSmooth applies a local likelihood smoother to smooth the DNA methylation across CpGs within genomic windows, assumes that data follow a binomial distribution and parameters are estimated by fitting linear model inside windows. It calculates signal-to-noise ratio statistic similar to t-test together with Empirical Bayes approach to test the difference for each CpG.
However, linear regression based methods might produce fitted methylation levels outside the range [0, 1] unless values are transformed before regression. An alternative is logistic regression which can deal with data strictly bounded between 0 and 1 and with non-constant variance, such as methylation proportion/fraction values. In the logistic regression, it is assumed that fitted values have variation np (1-p) , where p is the fitted methylation proportion for a given sample and n is the read coverage. If observed variance is larger or smaller than assumed by the model, one speaks of under or overdispersion. This over/under-dispersion can be corrected by calculating a scaling factor and using that factor to adjust the variance estimates as in np(1-p)s, where s is the scaling factor. methylKit package [41] can apply logistic regression to test the methylation difference with or without the overdispersion correction. In this case, Chi-square or F test can be used to compare the difference in the deviances of the null model and the alternative model. Null model assumes there is no relationship between sample groups and the methylation, and the alternative model assumes that there is a relationship where sample groups are predictive of methylation values for a given CpG or region for which the model is constructed.
More complex regression models use beta binomial distribution and they are particularly useful for better modeling the variance. Similar to logistic regression their observation follow binomial distribution (number of reads), but methylation proportion itself can vary across samples, according to a beta distribution. It can deal with fitting values in [0,1] range and performs better when there is more variance than expected by the simple logistic model. In essence, these models have a different way of calculating a scaling factor when there is overdispersion in the model. Further enhancements are made to these models by using the Empirical Bayes methods that can better estimate hyperparameters of beta distribution (variance-related parameters) by borrowing information between loci or regions within the genome to aid with inference about each individual loci or region. Some of the tools that rely on beta-binomial or beta model are as follows: MOABS [48] and DSS [49] , RADMeth [50] , BiSeq [48, 51] and methylSig [52] .
The choice of the which method to apply also depends on the data at hand. If one do not have replicates, the choice of tests are Fisher's Exact test (implemented in e.g. methylKit and RnBeads) or HMM-based methods such as comMet. If there are replicates tests based on regression are the natural choice rather than pooling the sample groups. Regression methods also have an advantage that one can add covariates into the tests such as technical/batch effects effects, age, sex, cell type heterogeneity, genetic effects. For instance, it has been shown that age is a contributing factor for methylation values at some CpGs [53, 54] and genetic heritability [55] . Covariates can be added to many methods such as methylKit, DSS, BSmooth and RnBeads.
The performance of various differential methylation methods are not very different and each method has its own advantages and disadvantages. To show this, we compared three classes of methods: 1) t-test/linear regression, 2) logistic regression and 3) beta binomial regression. For comparisons, we used both a simulated data set and biologically relevant data set where we expect differentially methylated bases in certain regions. For the simulated data set, we used three different tools: DSS (beta binomial regression), limma (linear regression), and methylKit (logistic regression with/without overdispersion correction). We simulated a dataset consisting of 6 samples (3 controls and 3 samples with treatment). The read coverage modeled by a binomial distribution. The methylation background followed a beta distribution with parameters alpha=0.4, beta=0.5 and theta=10. We simulated 5 sets of 5000 CpG sites where methylation at 50% of the sites was affected by the treatment to varying degrees -specifically, methylation was elevated by 5%, 10%, 15%, 20% and 25% in the test sample respectively in each set. To adjust p-values for multiple testing, we used q-value method [56] and we defined differentially methylated CpG sites with q-values below 0.01 for all examined methods. We calculated sensitivity, specificity and F-score for each of the three methods above. F-score refers to a way to measure sensitivity and specificity by calculating their harmonic mean. Limma detected the fewest DMCs and consequently number of true positives which leaded to the lowest sensitivity (see Figure 2 ). DSS had similar results to limma where both also have high specificity. MethylKit also performed well using either the Chi-squared or F test. MethylKit without overdispersion showed the lowest specificity. The overdispersion correction usually improves specificity. F-test with overdispersion has similar results to DSS, whereas Chi-squared test with overdispersion correction has similar specificity to stringent methods such as DSS and limma but achieves higher sensitivity. In addition, higher effect sizes results in higher sensitivity for all methods. Researchers should also consider a cutoff for the effect size or methylation difference in their analyses, as it is easier to detect changes with higher effect sizes but also smaller effect sizes may not be biologically meaningful. 5% change in methylation may not have an equivalent effect on gene expression and small changes may be within the range of the acceptable noise for biological systems.
Performance of different methods using simulated datasets are always a subject of debate. There are many different ways to simulate datasets and how the data is simulated can bias the performance metrics towards certain methods. Therefore, we also compared the performance of different methods using real bisulfite-sequencing experiments where we expect to see changes between samples on certain locations. Stadler and colleagues showed that DNA-binding factors can to create low-methylated regions upon binding [12] . They further show that the reduced methylation is a general feature of CTCF-occupied sites and if the site is unoccupied, the region on and around the site will have high methylation. This means that if the CTCF occupancy changes between two cell types, we expect to see a change in the methylation levels as well. Armed with this information, we looked for differentially methylated bases on regions that gained or lost CTCF binding between two cell types. We used the CTCF occupancy, binarized as peak present or peak lost, and the ENCODE RRBS data (where each cell line has two replicates) for 19 human cell lines [57] . We performed pairwise comparisons for each pair in all possible combinations of these 19 cell lines. We defined true positives as the number of CTCF peaks gained/lost between two cell lines which overlap at least one DMC. True negatives are defined as the number of CTCF peaks that do not change between cell lines and do not overlap any DMC although they are covered by RRBS reads. Accordingly, false positives are defined as the number of CTCF peaks that are present in both cell lines but overlap with at least one DMC, while false negatives are defined as peaks that are gained or lost between cell lines but have no DMC. We also down-sampled the CTCF peaks that do not change to match the number of peaks that change, to have a balanced classification performance, otherwise true negatives overwhelm performance metrics since there are many CTCF peaks that do not change. Differentially methylated CpGs were identified for all combinations of two cell lines using DSS, limma, methylKit and BSmooth. In the simulation data set, we did not model changes in methylation of nearby CpGs and since BSmooth assumes that the true methylation profile is smooth and uses a local smoother, it was not adequate to apply this method on simulation data and did not perform well.
For the CTCF dataset, we observed consistent results with the simulated dataset results ( Figure  3 ). limma has the highest specificity, however it detects extremely small number of true positives and has the lowest sensitivity. MethylKit without overdispersion had the highest F-score, but also the lowest specificity. With overdispersion, methylKit showed higher specificity close to DSS and BSmooth and second highest F-score. Taken together with the simulation results, methylKit without overdispersion can be used for more exploratory analysis as it achieves higher sensitivity but lower specificity, although it is still the best method when overall accuracy is considered. In contrast limma, DSS and methylKit F test with overdispersion correction can be applied when there is a need to limit false positive rates, such as when picking regions or CpGs for validation. A good compromise between stringent and relaxed methods seems to be Chi-squared test with overdispersion correction.
Defining differentially methylated regions
Most of the methods for differential methylation calling discussed earlier are designed to calculate both DMCs and DMRs. Some of them are designed to detect DMRs via aggregating DMC together within a predefined regions, such as CpG islands or CpG shores. RADmeth [50] and eDMR [58] groups P-values of adjacent CpGs and produce differentially methylated regions based on distance between differential CpGs and combination of their P-values using weighted Z-test. DSS set some thresholds on the P-values, number of CpG sites and length of regions before aggregation. Similarly, BSmooth defines DMRs by taking consecutive CpGs and cutoff based on the marginal empirical distribution of t and DMRs are ranked by sum of t-statistics in each CpG. BiSeq, on the other hand, first agglomerates CpG sites into clusters and smoothes methylation within clusters, uses beta regression and Wald test to test a group effect between control and test samples (with maximum likelihood with bias reduction). Apart from the various ways of clustering nearby CpGs or DMCs, many other methods rely on HMMs or other segmentation methods to segment the differential CpGs into hypo-and hyper-methylated regions and combine them to DMRs, such as MOABS, Methpipe, ComMet and methylKit.
Other methods define DMRs directly based on pre-defined windows. When input for functions for differential methylation calling are regions, so then data is summarized per region. The regions can be either predefined (such as regions with biological meaning like CpG islands) or use-defined with criteria like fixed region length for tilling windows that cover the whole genome, fixed numbers of significant adjacent CpG sites and smoothed estimated effect sizes.
Segmentation of the methylome
The analysis of methylation dynamics is not only restricted to differentially methylated regions across samples, apart from this there is also an interest in examining the methylation profiles within the same sample. Usually depressions in methylation profiles pinpoint regulatory regions like gene promoters that co-localize with CG-dense CpG islands. On the other hand many gene-body regions are extensively methylated and CpG-poor [1] . These observations would describe a bimodal model of either hyper-or hypomethylated regions dependent on the local density of CpGs [59] . However, with the detection of CpG-poor regions with locally reduced levels of methylation ( on average 30 % ) in pluripotent embryonic stem cells and in neuronal progenitors in both mouse and human a different model seems also reasonable [12] . These low-methylated regions (LMRs) are located distal to promoters, have little overlap with CpG islands and associated with enhancer marks such as p300 binding sites and H3K27ac enrichment.
The identification of these LMRs can be achieved by segmentation of the methylome using computational approaches. One of the well-known segmentation methods is based on a three state Hidden Markov Model (HMM) taking only DNA methylation into account, without knowledge of any additional genomic information such as CpG density or functional annotations [12] . The three states that the authors aimed for were fully methylated regions (FMRs), unmethylated regions (UMRs) and low-methylated regions (LMRs). This segmentation represents a summary of methylome properties and features, in which unmethylated CpG islands correspond to UMRs [5] , the majority is classified as FMR since most of the genome is methylated [60] and LMRs represent a new feature with intermediate levels of methylation, poor CpG content and shorter length compared to CpG islands [12] . Other segmentation methods such as methPipe assume a two model state HMM and can not differentiate between LMRs and UMRs.
The authors of the R package " MethylSeekR " [61] adapt the idea of a three feature methylome and additionally identify partially methylated domains (PMDs), another methylome feature found for instance in human fibroblast but not in H1 embryonic stem cells [2, 62] . These large regions (mean length = 153 kb) are characterized by highly disordered methylation with average levels of methylation below 70% and covering almost 40% of the genome [2, 62] . PMDs do not necessarily occur in every methylome, but they are detected using a sliding window statistic and genome wide identified with a HMM, as they need to be masked prior the characterization of UMRs / LMRs [61] .
There are also other segmentation strategies based on change-point analysis, where change-points of a genome wide signal are recorded and the genome is partitioned into regions between consecutive change points. This approach is typically used in the context of copy number variation detection [63] but can be applied to methylome segmentation as well. A package implementing this method of segmentation based on change points is methylKit, where the identified segments are further clustered using a mixture modeling approach. This clustering is based only on the average methylation level of the segments and allows the detection of distinct methylome features comparable to UMRs, LMRs and FMRs. This approach provides a more robust approach to segmentation where one can decide number of segment classes after segmentation whereas in HMM based methods one must know apriori number of segment classes or run multiple rounds HMMs with different numbers and identify which model fits better to the data.
Comparison of segmentation methods
We compared the change-point based segmentation to MethylSeekR, which is partially based on HMMs and but mainly using cutoffs for methylation values. We identified high-concordance between the two methods analysing the H1 embryonic stem cells methylome from the roadmap epigenomics project [64] . They describe regions with similar methylation values, segment lengths and genome annotation (Figure 4 ).
We also applied change-point based segmentation to a genome with PMDs. We segmented the Human IMR90 methylome into four distinct features ( Figure 5 ). We selected the feature with mean methylation level of segments closest to 50% to compare it to published PMDs [2, 62] . We overlapped all segments of this feature with the published regions and found that 81% of the generated segments of our feature overlap with the published regions of PMDs. Change-point based segmentation methods can also identify PMDs.
Strategies for dealing with large datasets
With rising numbers of publicly available epigenetic data we are tempted to reconstruct the results of published papers for many reasons, e.g. to better understand the reasoning behind steps the authors took or to get a general feeling for the data. In case of bisulfite sequencing data we might want to perform differential methylation analysis in R using whole genome methylation data of multiple samples. The problem is that for genome wide experiments file sizes can easily range from hundreds of megabytes to gigabytes and processing multiple instances of those files in memory (RAM) might become infeasible unless we have access to a high performance cluster (HPC) with lots of RAM. If we want to use a desktop computer or laptop with limited amount of RAM we either need to restrict our analysis on a subset of the data or use packages that can handle this situation.
The authors of the RADmeth package for differential methylation analysis advise to run the software on a "computing cluster with a few hundred available nodes" to allow the processing of multiple WGBS samples in reasonable time. The same analysis can as well be performed on a personal workstation with the disadvantage of increasing of computational time, which is in general dependent on three factors: the sample coverage, the number of sites analyzed and the number of samples. There exists one opportunity to speed up the time consuming regression step if your workstation is a multicore system. The authors included a script to split the input data into smaller pieces which could than be processed separately and merged afterwards using UNIX commands.
A package for the comprehensive analysis of genome-wide DNA methylation data that can handle large data is RnBeads [42] , which internally relies on the 'ff' package. The R package 'ff' [65] allows the work with datasets larger than available RAM by storing them as temporary files and providing an interface to enable reading and writing from flat files and operate on the parts that have been loaded into R.
The methylKit package provides very similar capability by exploiting flat file databases to substitute in-memory objects if the objects grow too large. The internal data apart from meta information has a tabular structure storing chromosome, start/end position, strand information of the associated CpG base just like many other biological formats like BED, GFF or SAM. By exporting this tabular data into a TAB-delimited file and making sure it is accordingly position sorted it can be indexed using the generic Tabix tool [66] . In general "Tabix indexing is a generalization of BAM indexing for generic TAB-delimited files. It inherits all the advantages of BAM indexing, including data compression and efficient random access in terms of few seek function calls per query." [66] . MethylKit relies on Rsamtools ( http://bioconductor.org/packages/release/bioc/html/Rsamtools.html ) which implements tabix functionality for R and this way internal methylKit objects can be efficiently stored as compressed file on the disk and still be fast accessed. Another advantage is that compressed files formerly created can be actually loaded in interactive sessions, allowing the backup and transfer of intermediate analysis results.
Annotation of DMRs/DMCs and segments
The regions of interest obtained through differential methylation or segmentation analysis often needs to be integrated with genome annotation datasets. Without this type of integration, differential methylation or segmentation results will be hard to interpret in terms of biology. The most common annotation task is to see where regions of interest land in relation to genes and gene parts and regulatory regions: Do they mostly occupy promoter, intronic or exonic regions ? Do they overlap with repeats ? Do they overlap with other epigenomic markers or long-range regulatory regions ? These questions are not specific to methylation, nearly all regions of interest obtained via genome-wide studies have to deal with such questions. There are multiple software tools that can produce such annotations. One is Bioconductor package genomation [67] . It can be used to annotate DMRs/DMCs and it can also be used to integrate methylation proportions over the genome with other quantitative information and produce meta-gene plots or heatmaps. Another similar package is ChIPpeakAnno [68] , which is designed for ChIP-seq peak annotation but could be used for DMR/DMC annotation to a certain degree.
Workflows and tools that do not require programming experience
Software packages for the analysis of whole genome bisulfite sequencing data perform computationally intensive tasks and are therefore hosted on advanced hardware infrastructures. Moreover, the majority of the tools require programming knowledge (e.g. writing R commands). If the local execution of those tools is not feasible due to insufficient processing power or expertise, using an online service could be an alternative. For example, an analysis workflow on the RnBeads web service is started by simply uploading the data and setting a handful of options through a web form. The limitations it imposes on file size, however, make it infeasible for large datasets. Galaxy is an open source, web-based platform for data intensive biomedical research (see https://galaxyproject.org ), providing access to publicly available servers and tools dedicated to data processing and analysis. A curated list of tools exists at https://toolshed.g2.bx.psu.edu hosting 4300 different programs for use within Galaxy at the time of writing, including methylKit https://toolshed.g2.bx.psu.edu/view/rnateam/methylkit/a8705df7c57f ) and RnBeads ( https://toolshed.g2.bx.psu.edu/view/pavlo-lutsik/rnbeads/6b0981ab063e ). WBSA is another freely available web service for WGBS and RRBS 1 ( http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0086707 ) data. It is a modular collection of custom scripts combined with widely used tools, such as BWA for alignment and FastQC for quality control. The focus of WBSA is on ease of use. Uploading data and setting up analysis parameters is achieved using a small web form. The main advantages of this service are support for genome assemblies from 10 species, support for a range of sequencing protocols, as well as extraction and analysis of non-CpG methylation. More flexibility can be achieved by downloading and locally installing the modules, however, installing the WBSA back-end is a non-trivial task as its long list of dependencies includes tools and libraries from heterogeneous platforms: Java, MySQL, Perl, and R.
Conclusions
In this review, we have discussed the experimental and the computational methods to measure and computationally analyse DNA methylation in genome-wide or targeted manner. We presented all the necessary steps of downstream analysis for bisulfite sequencing experiments starting from read alignment and quality check. We discussed and compared differential methylation and methylome segmentation methods. Our efforts for comparing differential methylation methods revealed that performances of different methods are comparable. One can choose methods based on the overall goal of their research. The methods that are stringent and limit the false positive rates are good for subsequent validation studies (DSS, limma, BSmooth, MethylKit with F test and overdispersion correction), however these methods sacrifice sensitivity (true positive rate) for sake of reducing false positives. A very relaxed method, such as default methylKit method, has the best accuracy overall but highest false positive rate. A good alternative to stringent and relaxed methods is Chi-square test after overdispersion correction (implemented in methylKit). This method has high sensitivity without sacrificing too much for specificity. For segmentation methods, we observed high-concordance between cutoff based methods and change-point analysis based methods. Change-point analysis methods are more flexible in the sense that they identify multiple biologically relevant segments within the same analysis. For example, HMM or cutoff based methods should first remove partially methylated domains (PMDs) from the analysis in order to define LMRs. Whereas change-point analysis based methods can identify LMRs and PMDs in the same analysis.
We believe through this guideline of methods for BS-seq analysis both bioinformaticians as well as experimental biologists will gain idea not only about experimental design, but also best practises for computational analysis. Overdispersion correction available only for methylKit has suffix "-OC". Effect size indicates methylation differences between two groups of samples. Replicates in one group had elevated methylation in 50% of CpGs sites by accordingly 5%, 10%, 15%, 20% and 25%. 
